Research.Patient.info
Medullary Thyroid Cancer research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE1, PHASE2
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
This study looks at a new medicine called Selpercatinib for children and young people (ages 6 months to 21 years) with certain advanced solid tumours or brain tumours. It's for those whose tumours have a specific genetic change (called RET alteration).
United States · Australia · Canada - active not recruitingPHASE2
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
This study looks at how well a medicine called larotrectinib works for children and young people with certain rare cancers that have a specific gene change (TRK fusion). It also checks for any side effects.
United States · Canada